Abstract
BACKGROUND Recent evidence suggests that window-view and window-ventilation may contribute to mental wellbeing. Compared to their younger counterparts, older adults spend more time at home and have less contact with natural environments due to social isolation and physical decline. However, the association of residential window-opening with depressive symptoms is understudied among older populations.
METHODS We used data from a community-based cohort study conducted in 23 provinces of China including 13,125 adults age 65 years or older (mean age: 83.8 years [SD: 11.1]). We created the window opening index (WOI) as a proxy of window-view and window-ventilation, leveraging relevant data on self-reported frequencies of manual window opening at home. Depressive symptoms were assessed by the 10-item version of the Centre for Epidemiological Studies Depression scale no fewer than 10. We used multivariate logistic regression model to examine the association between window opening and depressive symptoms.
RESULTS In the multivariate logistic regression model controlling for a set of well-designed mood-influencing environmental and individual-level covariates, a protective effect of window opening on depressive symptoms was observed, with 16% lower odds per interquartile increment in WOI (odds ratio: 0.84, 95%-CI: 0.81-0.87). Subgroup analyses indicated that the beneficial effects were more pronounced among those with higher socioeconomic status (higher levels of education, urban residents) and better surrounding environments (lower exposure of ambient fine particular matter, proximity to park, or higher levels of residential greenness).
DISCUSSION The results point to the benefits of well-designed household window-opening environments on the mental health of older populations and suggest a synergistic effect of window-opening and favorable surrounding natural environment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the National Key R&D Program of China (2018YFC2000400), National Natural Sciences Foundation of China (81903392, 81941021), and China Postdoctoral Science Foundation funded project (2019M650359).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The design of CLHLS was approved by the Campus Institutional Review Board of Duke University (Pro00062871) and the Biomedical Ethics Committee of Peking University (IRB00001052-13074).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data is avaliable from Peking University Open data plantform [https://opendata.pku.edu.cn/]